Loading provider…
Loading provider…
Radiation Oncology Physician in Bridgeport, CT
NPI: 1558346221Primary Practice Location
ST VINCENT'S MEDICAL CENTER
47 Long Lots Rd, Westport, CT
Primary Employer
Hartford Healthcare Medical Group Specialists, PLLC
hartfordhealthcaremedicalgroup.org
HQ Phone
Get MD Christopher's Phone Numberphone_androidMobile
Get MD Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCT State Medical License
CT State Medical License
2002 - 2025
NY State Medical License
1998 - 2025

American Board of Radiology
Radiation Oncology
Icahn School Of Medicine At Mount Sinai
icahn.mssm.edu
Residency • Radiation Oncology
1997 - 2000
Medical School
Until 1996
Brigham and Womens Hospital
Internship • Transitional Year
1996 - 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 67 | 86 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 44 | 44 |
| 3 | 77334Design and construction of complex radiation treatment device | 43 | 115 |
| 4 | 77263Complex radiation therapy planning | 43 | 46 |
| 5 | 77300Calculation of radiation therapy dose | 41 | 141 |
ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
Authors: Richard Stock
Publication Date: 2002-03
Authors: Shi, Chengyu, Chen, Yong, Fang, Deborah Xiangdong, Iannuzzi, Christopher
Journal: Med Dosim
Publication Date: 2014-08-27
Lead Sponsor: Radiation Therapy Oncology Group
Collaborators: National Cancer Institute (NCI), NRG Oncology
Intervention / Treatment: RADIATION: intensity-modulated radiation therapy, BIOLOGICAL: cetuximab
Lead Sponsor: Radiation Therapy Oncology Group
Collaborators: National Cancer Institute (NCI), NRG Oncology
Intervention / Treatment: DRUG: Sorafenib, RADIATION: stereotactic body radiation therapy
Lead Sponsor: Radiation Therapy Oncology Group
Collaborators: National Cancer Institute (NCI), NRG Oncology
Intervention / Treatment: DRUG: LHRH agonist (antagonist) therapy, RADIATION: Dose-Escalated Radiation Therapy, DRUG: bicalutamide, DRUG: flutamide